5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | BUY | BUY | BUY | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 0.08▼ | 0.08▲ | 0.08▼ | 0.06▲ | 0.06▲ |
MA10 | 0.08▼ | 0.08▼ | 0.08▲ | 0.05▲ | 0.11▼ |
MA20 | 0.08▲ | 0.08▲ | 0.07▲ | 0.06▲ | 0.19▼ |
MA50 | 0.08▼ | 0.06▲ | 0.06▲ | 0.13▼ | 0.41▼ |
MA100 | 0.08▲ | 0.06▲ | 0.06▲ | 0.20▼ | 0.72▼ |
MA200 | 0.07▲ | 0.06▲ | 0.06▲ | 0.35▼ | 1.22▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.000▲ | -0.001▼ | 0.001▲ | 0.008▲ | 0.000▲ |
RSI | 51.558▲ | 58.408▲ | 64.315▲ | 52.427▲ | 32.911▼ |
STOCH | 39.627 | 20.877 | 52.104 | 56.981 | 3.646▼ |
WILL %R | -40.816 | -56.941 | -50.000 | -33.114 | -87.213▼ |
CCI | 25.779 | -34.828 | 39.163 | 240.842▲ | -51.474 |
Friday, September 12, 2025 01:52 PM
Adaptimmune Therapeutics ( ($ADAP) ) just unveiled an update. On September 11, 2025, Adaptimmune Therapeutics received a notice from Nasdaq ...
|
Tuesday, September 02, 2025 12:35 PM
Gilead (NASDAQ:GILD) wants significant price hikes for several HIV drugs widely distributed by the state AIDS Drug Assistance Programs, a move that has caused concerns among ADAP directors, Stat News ...
|
Thursday, August 14, 2025 08:59 PM
Detailed price information for Adaptimmune Ther ADR (ADAP-Q) from The Globe and Mail including charting and trades.
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
16/09/25 | 0.0931 | 0.101 | 0.0742 | 0.0809 | 468,874,445 |
15/09/25 | 0.0637 | 0.069 | 0.0607 | 0.0666 | 93,327,079 |
12/09/25 | 0.052 | 0.06 | 0.0502 | 0.056 | 66,422,794 |
11/09/25 | 0.052 | 0.053 | 0.0491 | 0.0505 | 16,135,652 |
10/09/25 | 0.0482 | 0.0524 | 0.048 | 0.0508 | 22,978,046 |
09/09/25 | 0.0445 | 0.0518 | 0.043 | 0.0492 | 26,775,327 |
08/09/25 | 0.0403 | 0.046 | 0.0403 | 0.0425 | 28,906,645 |
05/09/25 | 0.0522 | 0.0522 | 0.0403 | 0.041 | 35,228,374 |
04/09/25 | 0.0531 | 0.0531 | 0.0473 | 0.051 | 29,263,375 |
03/09/25 | 0.0574 | 0.0579 | 0.0522 | 0.0526 | 37,140,220 |
|
|
||||
|
|
||||
|
|